Contents
In the Acadia Healthcare fraud case, the company agreed to pay $19.85 million to resolve allegations that it billed Medicare, Medicaid and TRICARE for unnecessary inpatient stays and care that failed to meet program requirements. The allegations reach decisions an admissions worker, nurse or therapist would recognize: who gets a bed, who stays in it, and whether the treatment in the chart actually happens.
The Department of Justice announced the civil settlement on September 26, 2024. It resolved claims from two qui tam cases brought by three former Acadia employees. One concerned Park Royal Hospital in Florida, and the other named Acadia and its Lakeview and Riverwoods operations in Georgia. The government’s investigation expanded to additional hospitals.
The government alleged that Acadia billed for patients who did not qualify for inpatient treatment, kept patients after they no longer needed that treatment, and failed to provide the care those stays required. Its allegations covered inadequate staffing, training and supervision, missing or outdated assessments and treatment plans, missing individual and group therapy, and inadequate discharge planning.
These were claims for active psychiatric treatment. The alleged failures reached both sides of the hospital bill: whether a patient needed the inpatient stay and what the hospital delivered during it. The government also alleged that staffing failures led to assaults, patients leaving without supervision, suicides and other harm.
The Justice Department’s settlement announcement names Park Royal Hospital and North Tampa Behavioral Health in Florida, and Lakeview Behavioral Health and Riverwoods Behavioral Health System in Georgia. Harbor Oaks Hospital in Michigan and Seven Hills Hospital in Nevada were also covered.
The whistleblower’s complaint describing the Georgia operations alleged an admissions policy that accepted referrals without regard to whether patients needed the services or the facility could properly evaluate and treat them. That is where the alleged billing mechanism started, before anyone wrote a therapy note.
According to the complaint, Lakeview typically kept Medicare patients for at least twelve days and sometimes thirty, regardless of their medical needs, treatment needs or progress. It also alleged that an executive directed intake staff away from physicians who favored shorter stays. Under that account, a physician’s willingness to discharge a patient could cost the physician the next referral.
The treatment meetings allegedly reflected the same priority:
Instead, Acadia personnel would meet to primarily discuss the patient census and to ensure that insurance was covering patients’ stays during treatment team meetings.
United States v. Acadia Healthcare Company, whistleblower’s complaint, paragraph 211
The complaint described the reverse decision when coverage ran out. Some Medicaid patients allegedly left promptly once Acadia could no longer bill for them, even without a physician’s or licensed nurse’s judgment supporting discharge. Read together, these allegations put insurance coverage at the center of both decisions: keep the patient while the stay pays, discharge the patient when it stops.
An employee who saw those decisions being made may understand a discrepancy that the bill alone cannot explain.
The staffing allegations connect the cost of running a hospital to the treatment it billed. The complaint alleged that a regional finance executive directed a facility executive to put only two registered nurses on duty for 58 patients and send two licensed practical nurses home.
It also alleged that managers hid staffing grids and ratios from outside surveyors. Those grids described the people available to do the work. A treatment plan could call for care that the shift was not staffed to provide.
The complaint’s account of discharge planning makes that gap concrete. It alleged that Lakeview had one discharge planner for all patients, and that the planner often could not say where departing patients were going, who would receive them or what care instructions their caregivers would get. Discharge planning was among the services the government said Acadia failed to provide adequately.
The laboratory allegations showed another break between ordering work and using it to treat a patient:
If the blood and urine tests were drawn from the patients, it was also common that no clinician at Acadia evaluated the results of the lab work or documented the results.
United States v. Acadia Healthcare Company, whistleblower’s complaint, paragraph 171
The complaint also alleged automatic billing for urine and blood testing regardless of whether a specimen had been collected. A test on the bill, a specimen in the laboratory and a result reviewed by a clinician were different parts of the treatment story. The whistleblower alleged failures across that chain.
For these allegations, the useful evidence connects the admission and continued stay to the treatment actually delivered, the staff available, the chart and the government claim. We examine those connections with the insider who understands how the hospital operated.
The complaint alleged that physician signatures were backdated to make records appear contemporaneous with care, even when a physician reviewed and signed them weeks or months afterward and after Acadia had submitted claims. It separately alleged that a risk manager shredded unsigned treatment plans or restraint orders and told an investigator the documents could not be found.
Those allegations explain why a completed chart can leave the important question unanswered. When was the entry made, who supplied it, and does it describe care that happened? Admission assessments, treatment plans, therapy notes, staffing grids and discharge records tell different parts of that story. The billing record connects them to the public money requested.
An admissions worker may know how coverage affected a placement. A nurse or therapist may know what care the shift could deliver. A billing employee may know what went out on the claim. Our work is to connect that operational knowledge to the company’s decisions and the payment it sought.
Acadia’s outpatient laboratory and North Carolina methadone cases concerned different services from the inpatient settlement. They are useful comparisons because each asks whether the billing records represented work the provider actually performed.
The government alleged that Acadia, acting through CRC Health, billed West Virginia Medicaid as though its outpatient treatment centers had performed urine and blood testing that an outside laboratory actually performed.
In the separate North Carolina case, a former assistant medical director alleged that Acadia’s methadone-treatment operations billed treatment bundles without required counseling and supported them with copied or fabricated notes.
Acadia operates across several treatment settings. Its annual report for 2025 reported 277 facilities at year-end, with acute inpatient psychiatry accounting for 55% of annual revenue. Its other businesses included specialty treatment, comprehensive treatment centers and residential centers.
Medicaid supplied 57.7% of Acadia’s revenue that year, and Medicare supplied 14.3%.
The payment systems also buy different units of care. Medicare’s inpatient psychiatric payment system uses an adjusted daily payment. Its opioid treatment program benefit pays for a weekly episode, with at least one qualifying drug or nondrug service during the week.
An inpatient day and an outpatient treatment bundle therefore call for different comparisons. The question we examine with an insider is what that payer paid for, what happened for that patient and what the company represented in its claim.
Acadia’s annual report also disclosed separate criminal grand jury subpoenas in 2024 concerning admissions, length of stay and billing.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
The Acadia inpatient settlement allocated $16,663,918 to the United States and $3,186,082 to Florida, Georgia, Michigan and Nevada. The agreement provided a shared federal whistleblower award of about $3.17 million for the three former employees who brought the two cases.
The cases began with employees who could describe what happened inside the hospitals.
If you saw coverage drive admissions, staffing fall short of treatment plans or notes describe care nobody delivered, talk with our whistleblower experts about your hospital’s billing. We build the case with you and bring in health care fraud whistleblower lawyers who understand inpatient psychiatric care and government claims. We stay beside you as your knowledge of the unit becomes a case for recovering the money.